JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB57030

Anti-PHGDH/Malate dehydrogenase antibody [4A3-1D6]

Be the first to review this product! Submit a review

|

(16 Publications)

Mouse Monoclonal PHGDH/Malate dehydrogenase antibody. Suitable for IP, Flow Cyt, WB, IHC-P, ICC/IF and reacts with Human samples. Cited in 16 publications. Immunogen corresponding to Recombinant Full Length Protein corresponding to Human PHGDH.

View Alternative Names

PGDH3, PHGDH, D-3-phosphoglycerate dehydrogenase, 3-PGDH, 2-oxoglutarate reductase, Malate dehydrogenase

6 Images
Flow Cytometry - Anti-PHGDH/Malate dehydrogenase antibody [4A3-1D6] (AB57030)
  • Flow Cyt

Unknown

Flow Cytometry - Anti-PHGDH/Malate dehydrogenase antibody [4A3-1D6] (AB57030)

Overlay histogram showing HeLa cells stained with ab57030 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab57030, 1μg/1x106 cells) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-mouse IgG (H+L) (ab96879) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was mouse IgG1 [ICIGG1] (ab91353, 2μg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed.

This image was generated using the ascites version of the product.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PHGDH/Malate dehydrogenase antibody [4A3-1D6] (AB57030)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PHGDH/Malate dehydrogenase antibody [4A3-1D6] (AB57030)

Immunohistochemical analysis of formalin-fixed paraffin-embedded human lymph node tissue labeling PHGDH with an antibody concentration of 3 µg/ml.

Positive staining on human lymph node tissue.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PHGDH/Malate dehydrogenase antibody [4A3-1D6] (AB57030)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PHGDH/Malate dehydrogenase antibody [4A3-1D6] (AB57030)

Immunohistochemical analysis of formalin-fixed paraffin-embedded human prostate tissue labeling PHGDH with an antibody concentration of 3 µg/mL.

Positive staining on human prostate tissue.

Immunoprecipitation - Anti-PHGDH/Malate dehydrogenase antibody [4A3-1D6] (AB57030)
  • IP

Unknown

Immunoprecipitation - Anti-PHGDH/Malate dehydrogenase antibody [4A3-1D6] (AB57030)

PHGDH/Malate dehydrogenase was immunoprecipitated using 0.5mg Jurkat whole cell extract, 10μg of Mouse monoclonal to PHGDH/Malate dehydrogenase and 50μl of protein G magnetic beads (+). No antibody was added to the control (-).
The antibody was incubated under agitation with Protein G beads for 10min, Jurkat whole cell extract lysate diluted in RIPA buffer was added to each sample and incubated for a further 10min under agitation.
Proteins were eluted by addition of 40μl SDS loading buffer and incubated for 10min at 70oC; 10μl of each sample was separated on a SDS PAGE gel, transferred to a nitrocellulose membrane, blocked with 5% BSA and probed with ab57030.
Secondary : Goat polyclonal to mouse IgG light chain specific (HRP) at 1/5000 dilution.
Band : 57kDa; PHGDH/Malate dehydrogenase.

This image was generated using the ascites version of the product.

All lanes:

Immunoprecipitation - Anti-PHGDH/Malate dehydrogenase antibody [4A3-1D6] (ab57030)

Predicted band size: 57 kDa

false

Western blot - Anti-PHGDH/Malate dehydrogenase antibody [4A3-1D6] (AB57030)
  • WB

Unknown

Western blot - Anti-PHGDH/Malate dehydrogenase antibody [4A3-1D6] (AB57030)

PHGDH/Malate dehydrogenase antibody (ab57030) at 1μg/ml + Jurkat cell lysate at 25μg/lane.

This image was generated using the ascites version of the product.

All lanes:

Western blot - Anti-PHGDH/Malate dehydrogenase antibody [4A3-1D6] (ab57030)

Predicted band size: 57 kDa

false

Western blot - Anti-PHGDH/Malate dehydrogenase antibody [4A3-1D6] (AB57030)
  • WB

CiteAb

Western blot - Anti-PHGDH/Malate dehydrogenase antibody [4A3-1D6] (AB57030)

PHGDH/Malate dehydrogenase western blot using anti-PHGDH/Malate dehydrogenase antibody [4A3-1D6] ab57030. Publication image and figure legend from Kitazawa, S., Ebara, S., et al., 2017, Oncotarget, PubMed 28423651.

ab57030 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab57030 please see the product overview.

Metabolic switch from aerobic metabolism to glycolysis in SDHB-deficient cells(A) Relative values of OCR and ECAR of HCT116 SDHB knockout cells (#7 and #23) were obtained by setting the OCR and ECAR values of the control cells as 1. The OCR and ECAR were analyzed using an XF96 extracellular flux analyzer (n = 12). Data are given as means ± SD. (B) Metabolite concentrations of pyruvate and lactate were measured using CE-MS 48 and 96 h after cell seeding in HCT116 SDHB knockout cells (#7 and #23) and control cells (n = 3). Data are given as means ± SD. *p < 0.05, **p < 0.01, ***p < 0.001 by the Bonferroni's corrected t-test. (C) Metabolites and enzymes in the glycolysis pathway and its derived pathways. Metabolite abundance 48 h after cell seeding was analyzed using CE-MS (n = 3). Ordinate values were obtained by setting the control group value 48 h after cell seeding as 100%. Data are given as means ± SD. ND : not detected. ND : the metabolite concentration was below the detection limit of the analysis. (D) Expression levels of SDHB, PHGDH, PSAT1, PSPH, and β-actin were determined by western blot 64 h after cell seeding.

false

Key facts

Host species

Mouse

Clonality

Monoclonal

Clone number

4A3-1D6

Isotype

IgG1

Light chain type

kappa

Carrier free

No

Reacts with

Human

Applications

IHC-P, Flow Cyt, IP, ICC/IF, WB

applications

Immunogen

Recombinant Full Length Protein corresponding to Human PHGDH.

O43175

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "FlowCyt-species-checked": "testedAndGuaranteed", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "<p><a href='/en-us/products/primary-antibodies/mouse-igg1-kappa-monoclonal-15-6e10a7-isotype-control-ab170190'>ab170190</a> - Mouse monoclonal IgG1, is suitable for use as an isotype control with this antibody.</p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "", "WB-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>" } } }

Product details

This product was changed from ascites to tissue culture supernatant on 24/1/19. Please note that the dilutions may need to be adjusted accordingly. If you have any questions, please do not hesitate to contact our scientific support team.

Properties and storage information

Form
Liquid
Purity
Tissue culture supernatant
Purification notes
Purified from TCS.
Storage buffer
pH: 7.4
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Phosphoglycerate dehydrogenase also known as PHGDH is an enzyme that catalyzes the conversion of 3-phosphoglycerate to 3-phosphohydroxypyruvate. It has an approximate mass of 57 kDa. The PHGDH is located in the cytoplasm and mitochondria where it plays a role in serine biosynthesis. Malate dehydrogenase might also get mentioned together with PHGDH because both enzymes link to metabolic processes. The expression of PHGDH is noted in various tissues with higher levels observed in some cancer cells.
Biological function summary

PHGDH is essential for the serine synthesis pathway and cellular metabolism regulation. It does not form part of large complexes but operates independently to convert substrates necessary for cell growth and proliferation. The enzyme supports the synthesis of nucleotides and proteins impacting cell cycle and survival. Researchers investigate PHGDH to understand its role in metabolic reprogramming especially in cancer cells.

Pathways

PHGDH is important in the serine biosynthesis pathway which is part of the larger glycolytic process. It connects to pathways that contribute to cellular carbon metabolism and energy production. PHGDH interacts with glutamate dehydrogenase protein (GDH) and also influences one-carbon metabolism and redox balance within the cell. These pathways play important roles in providing building blocks for nucleotide and lipid biosynthesis.

PHGDH has relevance in cancer and neurological disorders. Alterations and overexpression of PHGDH have been linked to oncogenesis and tumor growth particularly in breast cancer. The enzyme also associates with neurodegenerative diseases as proper serine levels are important for neuron function. In both conditions PHGDH becomes connected with glutamate dehydrogenase as alterations can impact amino acid metabolism and neurotransmitter balance. The study of PHGDH inhibitors is gaining attention for therapeutic potentials in these diseases.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Catalyzes the reversible oxidation of 3-phospho-D-glycerate to 3-phosphonooxypyruvate, the first step of the phosphorylated L-serine biosynthesis pathway. Also catalyzes the reversible oxidation of 2-hydroxyglutarate to 2-oxoglutarate and the reversible oxidation of (S)-malate to oxaloacetate.
See full target information PHGDH

Publications (16)

Recent publications for all applications. Explore the full list and refine your search

Cancer biology & medicine 22: PubMed40434360

2025

Nuclear PHGDH regulates macrophage polarization through transcriptional repression of and in breast cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Pei Wang,Xin Du,Zhiren Han,Jiaxin Zhong,Jiayu Yuan,Lin Jiang,Beinan Han,Wenkui Fu,Hongde Li,Hai Hu,Zhenkun Na

Cell death & disease 15:378 PubMed38816356

2024

CBX4 plays a bidirectional role in transcriptional regulation and lung adenocarcinoma progression.

Applications

Unspecified application

Species

Unspecified reactive species

Ran Zhao,Yanxuan Guo,Linlin Zhang,Zhiyong Huang,Xuanyuan Li,Bei Lan,Diansheng Zhong,Hao Chen,Chenghao Xuan

Nature communications 14:1011 PubMed36823188

2023

PHGDH arginine methylation by PRMT1 promotes serine synthesis and represents a therapeutic vulnerability in hepatocellular carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Kui Wang,Li Luo,Shuyue Fu,Mao Wang,Zihao Wang,Lixia Dong,Xingyun Wu,Lunzhi Dai,Yong Peng,Guobo Shen,Hai-Ning Chen,Edouard Collins Nice,Xiawei Wei,Canhua Huang

Diagnostics (Basel, Switzerland) 12: PubMed35204409

2022

Identification of Novel Diagnostic Markers for Malignant Pleural Mesothelioma Using a Reverse Translational Approach Based on a Rare Synchronous Tumor.

Applications

Unspecified application

Species

Unspecified reactive species

Tomoaki Naka,Yutaka Hatanaka,Yukiko Tabata,Akira Takasawa,Hideo Akiyama,Yasuhiro Hida,Hiromi Okada,Kanako C Hatanaka,Tomoko Mitsuhashi,Kei Kushitani,Vishwa Jeet Amatya,Yukio Takeshima,Kouki Inai,Kichizo Kaga,Yoshihiro Matsuno

Cells 10: PubMed34831219

2021

Death-Associated Protein Kinase 1 Inhibits Progression of Thyroid Cancer by Regulating Stem Cell Markers.

Applications

Unspecified application

Species

Unspecified reactive species

Mi-Hyeon You,Woo Kyung Lee,Meihua Jin,Dong Eun Song,Sheue-Yann Cheng,Tae Yong Kim,Won Bae Kim,Min Ji Jeon,Won Gu Kim

Translational lung cancer research 10:2523-2538 PubMed34295659

2021

One carbon metabolism in human lung cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Sha Yao,Luogen Peng,Omar Elakad,Stefan Küffer,Marc Hinterthaner,Bernhard C Danner,Alexander von Hammerstein-Equord,Philipp Ströbel,Hanibal Bohnenberger

Cancers 13: PubMed33916579

2021

Biochemical Background in Mitochondria Affects 2HG Production by IDH2 and ADHFE1 in Breast Carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Jitka Špačková,Klára Gotvaldová,Aleš Dvořák,Alexandra Urbančoková,Kateřina Pospíšilová,David Větvička,Alberto Leguina-Ruzzi,Petra Tesařová,Libor Vítek,Petr Ježek,Katarína Smolková

Frontiers in oncology 10:1277 PubMed32974128

2020

Metabolic Profiling of Ovarian Cancer Tumor Xenografts: A Digital Pathology Approach.

Applications

Unspecified application

Species

Unspecified reactive species

Ilaria Piga,Martina Verza,Francesca Montenegro,Giorgia Nardo,Elisabetta Zulato,Tiziana Zanin,Paola Del Bianco,Giovanni Esposito,Stefano Indraccolo

Thyroid : official journal of the American Thyroid Association 30:1625-1638 PubMed32438862

2020

High Phosphoglycerate Dehydrogenase Expression Induces Stemness and Aggressiveness in Thyroid Cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Min Ji Jeon,Mi-Hyeon You,Ji Min Han,Soyoung Sim,Hyun Ju Yoo,Woo Kyung Lee,Tae Yong Kim,Dong Eun Song,Young Kee Shong,Won Gu Kim,Won Bae Kim

Cell cycle (Georgetown, Tex.) 18:2509-2523 PubMed31397203

2019

LncRNA MALAT1/miR-181a-5p affects the proliferation and adhesion of myeloma cells via regulation of Hippo-YAP signaling pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Yanbei Sun,Tingxiu Jiang,Yongqing Jia,Jingyun Zou,Xiaoxiao Wang,Weiying Gu
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com